NASHVILLE, Tenn., Feb. 27, 2020 /PRNewswire/ -- Cryoport, Inc.
(NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport" or the "Company"), a
global leader in life sciences solutions, today announced that the
Company will report financial results for the fourth quarter and
fiscal year ended December 31, 2019
on Thursday, March 5, 2020 after U.S.
markets close.
In addition to the earnings release, a document titled "Cryoport
2019 Year in Review", which will provide a review of Cryoport's
recent financial and operational performance and a general business
update, will be issued by management at 4:05 pm ET on Thursday, March 5, 2020. The document is designed
to be read by investors before the questions and answers conference
call and can be accessed at
http://ir.cryoport.com/events-and-presentations.
Cryoport management will host a conference call at 5:00 pm ET on March 5,
2020. The conference call will be in the format of a
questions and answers session and will address any queries
investors have regarding the Company's reported results.
Conference Call Information
Date:
|
March 5,
2020
|
Time:
|
5:00 p.m.
ET
|
Dial-in
numbers:
|
+1 (855) 327-6837
(U.S.), +1 (631) 891-4304 (International)
|
Confirmation
code:
|
Request the "Cryoport
Call"
|
Live
webcast:
|
'Investor Relations'
section at www.cryoport.com or at this link. Please allow 10
minutes prior to the call to visit this site to download and
install any necessary audio software.
|
An archive of the question and answer webcast will be available
approximately three hours after completion of the live event and
will be accessible on the Investor Relations section of the
Company's website at www.cryoport.com for a limited time. To
access the replay of the webcast, please follow this link. A
dial-in replay of the call will also be available to those
interested until March 12, 2020. To
access the replay, dial +1 (844) 512-2921 (United States) or +1 (412) 317-6671
(International) and enter replay pin number: 10008682.
About Cryoport, Inc.
Cryoport, Inc. (Nasdaq: CYRX) is redefining logistics by
providing a platform of temperature-controlled solutions for the
life sciences industry, serving the Biopharma, Human Reproductive,
and Animal Health markets. Our mission is to support life and
health on earth by providing reliable and comprehensive solutions
for the life sciences through our advanced technologies, Global
Supply Chain Network and dedicated scientists, technicians and
supporting team of professionals. Through purpose-built proprietary
packaging; information technology; smart, sustainable cold chain
logistics; and biostorage/biobanking services, Cryoport helps its
customers advance life sciences research, support life-saving
advanced therapies and deliver vaccines, protein producing
materials, and IVF treatments in over 100 countries around the
world. For more information, visit www.cryoport.com or follow
@cryoport on Twitter at www.twitter.com/cryoport for live
updates.
Forward Looking Statements
Statements in this news release which are not purely
historical, including statements regarding Cryoport, Inc.'s
intentions, hopes, beliefs, expectations, representations,
projections, plans or predictions of the future are forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. It is important to note that the Company's
actual results could differ materially from those in any such
forward-looking statements. Factors that could cause actual results
to differ materially include, but are not limited to, risks and
uncertainties associated with the effect of changing economic
conditions, trends in the products markets, variations in the
Company's cash flow, market acceptance risks, and technical
development risks. The Company's business could be affected by a
number of other factors, including the risk factors listed from
time to time in the Company's U.S. Securities and Exchange
Commission (SEC) reports including, but not limited to, the
Company's 10-K for the year ended December
31, 2018 filed with the SEC. The Company cautions investors
not to place undue reliance on the forward-looking statements
contained in this press release. Cryoport, Inc. disclaims any
obligation, and does not undertake to update or revise any
forward-looking statements in this press release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cryoport-to-report-fourth-quarter-and-fiscal-year-2019-financial-results-on-march-5-2020-301012102.html
SOURCE Cryoport, Inc.